Navigation Links
MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
Date:1/16/2008

FDA evaluates clinical protocols and may achieve agreement with sponsors and applicants on the design and size of the studies and clinical trials that can be used for approval of a drug. It is intended to provide assurance that if pre-specified trial results are achieved, they may serve as the primary basis for an efficacy claim in support of a new drug application. In general, these assessments are considered binding on the FDA as well as the sponsor unless public health concerns unrecognized at the time the SPA is entered into become evident or other new scientific concerns regarding product safety or efficacy arise.

About MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals develops and plans to commercialize new therapies for children and adults who suffer from diseases that the company believes are not treated adequately by currently available medicines. The company uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs, while minimizing risk, by capitalizing on their known safety, efficacy and commercialization history. The company has several proprietary product candidates in clinical development that address large market opportunities, including its two most advanced product candidates: UDB, a proprietary version of nebulized budesonide for the potential treatment of children with asthma, and MAP0004, a proprietary version of orally inhaled dihydroergotamine delivered by MAP Pharmaceuticals' proprietary Tempo inhaler for the potential treatment of migraine. In addition to UDB and MAP0004, MAP Pharmaceuticals has other proprietary product candidates in clinical development that also address large market opportunities, including a proprietary combination of an inhaled corticosteroid with a long-acting beta2-agonist for the potential treatment of asthma and chronic obstructive pulmonary disease.

Additional information about MAP Pharmaceuticals can be found at

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
2. Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
3. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
4. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
5. NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
6. ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily)
7. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
8. Idenix Pharmaceuticals to Present at the JP Morgan 26th Annual Healthcare Conference
9. Cogentus Pharmaceuticals Completes $62.5 Million Private Financing
10. Cumberland Pharmaceuticals Announces Appointments
11. Pacira Pharmaceuticals Names David M. Stack CEO and President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014 Chinese researchers say a protein ... plasma can be used as a prognostic indicator in people ... read the full article on the study , just posted ... Department of Respiratory Medicine at Shandong University Hospital in China ... patients between 1995 and 2013. They found that, the ...
(Date:7/30/2014)... AttorneyOne.com, a recognized authority on law, ... from the FDA on snacks . , Dancing ... are recalled because they contain organic Carob ... salmonella. Salmonella can cause serious, fatal infections in people ... cause abdominal pain, vomiting, nausea, diarrhea, or fever. In ...
(Date:7/30/2014)... Seattle, Wa (PRWEB) July 30, 2014 According ... by Vkool.com, this is a comprehensive guide that will help ... quickly within a few weeks. This book uncovers to readers ... candida infection. In addition, inside this book, people will discover ... yeast infection such as itching, burning, and irritation of ...
(Date:7/30/2014)... 30, 2014 The San Diego personal injury ... are announcing that they are now offering free case reviews ... asbestos exposure. , “Symptoms of asbestos exposure can take ... toxin 30 plus years ago may just now be suffering ... Law Office of Melinda J. Helbock A.P.C. “We want people ...
(Date:7/29/2014)... New York, NY (PRWEB) July 30, 2014 ... profile European fertility centers have been added to the ... Positivity continues to develop out of joint efforts — ... Cyprus create an initiative to offer affordable, state-of-the-art, and ... fertility clinics begins with a comprehensive study by ...
Breaking Medicine News(10 mins):Health News:Study Finds Common Blood Protein May Predict Mesothelioma Survival, Reports Surviving Mesothelioma 2Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 2Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 3Health News:The Law Office of Melinda J. Helbock A.P.C. Offers Case Evaluations for Possible Asbestos Claims 2Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4
... insight into a previously undescribed mechanism that regulates ... Cell Press in the February 29th issue of ... processes that contribute to breast cancer. , It ... plays key roles in cell growth, reproduction, metabolism ...
... Bloomington is a major source of drinking water for ... nitrate concentrations that exceed safe levels. Because Lake Bloomington ... are concerned over their drinking water quality. , Kenneth ... with a team of colleagues, present an article about ...
... sterilization technology developed at the University at Buffalo has ... challenged, including airborne spores, viruses and bacteria in independent ... , A prototype produced by Buffalo BioBlower Technologies LLC, ... level of better than one part per million in ...
... Brings Together Distinguished Panel of Dental Experts to Advance ... the Art, Science and Knowledge of CCLAD in Dentistry, ... Bulletin Board: MLSS), the recognized leader in,advanced injection technologies, ... First International Computer-Controlled Local Anesthetic,Delivery (CCLAD) Summit in New ...
... That Raising Families Out of Poverty on Average ... Programs Boosts Economic,Development, LOS ANGELES, Feb. 28 ... advocates will convene today at the Milken,Institute for ... Investment,to discuss strengthening the United States economy through ...
... Moving program motivates people to stay active, helps reduce arthritis ... ... the USA announced today a,partnership with McNeil Consumer Healthcare, the maker ... programs,stay active and reduce arthritis pain. Through this new collaboration,participating YMCAs ...
Cached Medicine News:Health News:Atypical protein kinase C stabilizes SRC-3 levels in breast cancer cells 2Health News:UB's bioblower closer to protecting soldiers from biological attack 2Health News:UB's bioblower closer to protecting soldiers from biological attack 3Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 2Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 3Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 4Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 5Health News:Business Leaders, Policy Makers and Advocates Gather to Discuss Strategies for Securing the Nation's Economy by Investing in Early Childhood 2Health News:Business Leaders, Policy Makers and Advocates Gather to Discuss Strategies for Securing the Nation's Economy by Investing in Early Childhood 3Health News:YMCA of the USA and McNeil Consumer Healthcare Partner to Promote Health for Older Adults 2Health News:YMCA of the USA and McNeil Consumer Healthcare Partner to Promote Health for Older Adults 3
(Date:7/29/2014)... July 29, 2014 According to ... "Orthopedic Trauma Fixation Devices Market - Global Forecast, Market ... the global orthopedic trauma fixation devices market is estimated ... to grow at a CAGR of 7.2% from 2014 ... 9.3 billion in 2020. Browse the Orthopedic ...
(Date:7/29/2014)... , July 29, 2014  Instrumentation Laboratory (IL) today announced ... new corporate logo. This is part of a comprehensive rebranding ... Founded in Boston, MA , in 1959, ... companies since 1992.  Other companies in the group include Inova ... Systelab ( Barcelona, Spain ).  Like IL, these ...
(Date:7/29/2014)... DUBLIN , July 29, 2014 ... the "Global Respiratory Devices Market 2014-2018" report ... A respiratory device is a medical ... who is having difficulty in breathing and cannot achieve ... disorders such as cystic fibrosis, asthma, COPD, and ARDS ...
Breaking Medicine Technology:Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3Global Respiratory Devices Market 2014-2018 2
... MOSCOW, Jan. 3, 2012 Goodwin Biotechnology, Inc. (GBI) ... announced an agreement for cell line engineering and manufacturing ... line. The monoclonal antibody will be engineered by GBI,s ... lines, select the highest producer and manufacture the monoclonal ...
... 3, 2012 /PRNewswire-Asia/ -- The Ministry of Health and Welfare ... Kyung-Hwa) announced that a 19-year-old woman, Tan Hui-Linn, has been ... Korea project and will receive surgery at the JK Plastic ... life that was once full of hopes shattered on Oct. ...
Cached Medicine Technology:Goodwin Biotechnology and OncoMax, a Maxwell Biotech Portfolio Company, Announce a "Bench-to-Clinic" Collaboration for an Important Advance in Oncology 2Goodwin Biotechnology and OncoMax, a Maxwell Biotech Portfolio Company, Announce a "Bench-to-Clinic" Collaboration for an Important Advance in Oncology 3Acid Attack Victim from Malaysia Restores Her Lost Face with Support of Medical Korea 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: